Role of Instructions in Nitrous Oxide Effects and Choice - 10
NCT ID: NCT00000258
Last Updated: 2015-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
1996-04-30
1997-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8
NCT00000256
Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
NCT00000252
Effects of Nitrous Oxide: A Dose-Response Analysis - 5
NCT00000253
Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
NCT00000255
Marijuana Drug Discrimination and Self-Administration
NCT00943930
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Informed group
Group inhaled placebo and varying doses of nitrous oxide in pairs then chose which they wanted for a third inhalation.
Nitrous oxide 10% & placebo
Nitrous oxide 20% & placebo
Nitrous oxide 30% & placebo
Nitrous oxide 40% and placebo
Non-informed Group
Group and technician were blinded as to which gas they were inhaling in pairs with third inhalation subject's choice.
Nitrous oxide 10% & placebo
Nitrous oxide 20% & placebo
Nitrous oxide 30% & placebo
Nitrous oxide 40% and placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nitrous oxide 10% & placebo
Nitrous oxide 20% & placebo
Nitrous oxide 30% & placebo
Nitrous oxide 40% and placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
21 Years
32 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
University of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Zacny, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Chicago
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Chicago, Anesthesia & Critical Care
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zacny JP, Cho AM, Toledano AY, Galinkin J, Coalson DW, Klock PA, Klafta JM, Young CJ. Effects of information on the reinforcing, subjective, and psychomotor effects of nitrous oxide in healthy volunteers. Drug Alcohol Depend. 1997 Nov 25;48(2):85-95. doi: 10.1016/s0376-8716(97)00114-2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R01-08391-10
Identifier Type: -
Identifier Source: secondary_id
NIDA-08391-10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.